Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer

BACKGROUND: Small cell lung cancer (SCLC) represents approximately 15% of lung cancers, and approximately 70% are diagnosed as extensive‐stage SCLC (ES‐SCLC). Although ES‐SCLC is highly responsive to chemotherapy, patients typically progress rapidly, and there is an urgent need for new therapies. Im...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncologist
Main Authors: Melosky, Barbara, Cheema, Parneet K., Brade, Anthony, McLeod, Deanna, Liu, Geoffrey, Price, Paul Wheatley, Jao, Kevin, Schellenberg, Devin D., Juergens, Rosalyn, Leighl, Natasha, Chu, Quincy
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Inc. 2020
主題:
Lung Cancer
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648366/
https://ncbi.nlm.nih.gov/pubmed/32860288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0193
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍